ADC Therapeutics S.A. (ADCT)
NYSE · Healthcare
ADC Therapeutics S.A. annual/quarterly total liabilities history from 2022 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- ADC Therapeutics S.A. total liabilities for the quarter ending December 31, 2025 were 509.0M, a 2.98% decrease year-over-year.
- ADC Therapeutics S.A. total liabilities for 2025 were 509.0M, a 2.98% decrease from 2024.
- ADC Therapeutics S.A. total liabilities for 2024 were 524.6M, a 4.29% increase from 2023.
- ADC Therapeutics S.A. total liabilities for 2023 were 503.0M, a 22.27% increase from 2022.
- ADC Therapeutics S.A. total liabilities for 2022 were 411.4M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| ADC Therapeutics S.A. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $509 |
| 2024 | $525 |
| 2023 | $503 |
| 2022 | $411 |
| ADC Therapeutics S.A. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $509 |
| 2024-12-31 | $525 |
| 2023-12-31 | $503 |
| 2022-12-31 | $411 |
ADC Therapeutics S.A. Total Liabilities — FAQ
ADC Therapeutics S.A. (ADCT) total liabilities over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADCT's total liabilities history?
The chart and table above show ADC Therapeutics S.A.'s total liabilities by year and by quarter, including the growth rate.